Keyphrases
Cancer Resistance
100%
Cellular Redox Status
16%
Chemoresistance
66%
Chemotherapy-induced
100%
Cisplatin Treatment
16%
Clinical Outcomes
16%
Clinically Significant
16%
Cotinine
33%
DNA Damage
100%
First-line Therapy
16%
Lung Cancer Treatment
50%
Major Metabolites
16%
Nicotine
100%
Nicotine Exposure
16%
Nicotinic Acetylcholine Receptor (nAChR)
100%
Non-small Cell Lung Cancer Cells
33%
Physiologically Relevant
16%
Platinum Therapy
16%
Platinum-based Chemotherapy
50%
Redox
100%
Redox Processes
16%
Self-defense Mechanism
16%
Small Cell Lung Cancer
100%
Tobacco Cessation
16%
Topoisomerase Inhibitors
16%
Medicine and Dentistry
Cancer Cell
25%
Cancer Therapy
25%
Cisplatin
12%
Cotinine
25%
DNA Damage
100%
Drug Resistance
100%
In Vitro
12%
Metabolite
12%
Small Cell Lung Cancer
100%
Smoke
12%
Topoisomerase Inhibitor
12%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
100%
Cisplatin
12%
Cotinine
25%
DNA Topoisomerase Inhibitor
12%
Drug Resistance
100%
Small Cell Lung Cancer
100%
Immunology and Microbiology
Cancer Cell
40%
DNA Damage
100%
Drug Resistance
100%
In Vitro
20%
Metabolite
20%
Oxidation Reduction Reaction
20%